دورية أكاديمية
Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy
| العنوان: | Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy |
|---|---|
| المؤلفون: | Falcetta, Pierpaolo, Aragona, Michele, Ciccarone, Annamaria, Bertolotto, Alessandra, Campi, Fabrizio, Coppelli, Alberto, Dardano, Angela, Giannarelli, Rosa, Bianchi, Cristina, Del Prato, Stefano |
| المساهمون: | Falcetta, Pierpaolo, Aragona, Michele, Ciccarone, Annamaria, Bertolotto, Alessandra, Campi, Fabrizio, Coppelli, Alberto, Dardano, Angela, Giannarelli, Rosa, Bianchi, Cristina, Del Prato, Stefano |
| سنة النشر: | 2021 |
| المجموعة: | ARPI - Archivio della Ricerca dell'Università di Pisa |
| مصطلحات موضوعية: | Age, Covid-19, Insulin therapy, Lockdown, Metabolic control, Type 2 diabete, Aged, Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 2, Female, Human, Italy, Male, SARS-CoV-2 |
| الوصف: | Aims: to evaluate the effect of home confinement related to COVID-19 lockdown on metabolic control in subjects with T2DM in Italy. Methods: we evaluated the metabolic profile of 304 individuals with T2DM (65% males; age 69±9years; diabetes duration 16±10years) attending our Diabetes Unit early at the end of lockdown period (June 8 to July 7, 2020) and compared it with the latest one recorded before lockdown. Results: There was no significant difference in fasting plasma glucose (8.6±2.1 vs 8.8±2.5mmol/L; P=0.353) and HbA1c (7.1±0.9 vs 7.1±0.9%; P=0.600) before and after lockdown. Worsening of glycaemic control (i.e., ΔHbA1c≥0.5%) occurred more frequently in older patients (32.2% in>80years vs 21.3% in 61-80years vs 9.3% in<60years; P=0.05) and in insulin users (28.8 vs 16.5%; P=0.012). On multivariable analysis, age>80years (OR 4.62; 95%CI: 1.22-16.07) and insulin therapy (OR 1.96; 95%CI: 1.10-3.50) remained independently associated to worsening in glycaemic control. Conclusions: Home confinement related to COVID-19 lockdown did not exert a negative effect on glycaemic control in patients with T2DM. However, age and insulin therapy can identify patients at greatest risk of deterioration of glycaemic control. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | ELETTRONICO |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/33722703; info:eu-repo/semantics/altIdentifier/wos/WOS:000647677900012; volume:174; numberofpages:5; journal:DIABETES RESEARCH AND CLINICAL PRACTICE; https://hdl.handle.net/11568/1116723Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103275233; https://www.sciencedirect.com/science/article/pii/S0168822721001030Test |
| DOI: | 10.1016/j.diabres.2021.108750 |
| الإتاحة: | https://doi.org/10.1016/j.diabres.2021.108750Test https://hdl.handle.net/11568/1116723Test https://www.sciencedirect.com/science/article/pii/S0168822721001030Test |
| حقوق: | info:eu-repo/semantics/restrictedAccess |
| رقم الانضمام: | edsbas.4271B6FC |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.diabres.2021.108750 |
|---|